We suspect that the high level of ISR-GCN2 activity in Vκ*MYC mice with early disease reflects an adaptive mechanism employed by myeloma cells to cope with cellular stress associated with transformation, but whether this is directly mediated by MYC has yet to be determined. Here, MYC is linked to plasma cell myeloma.